1. Home
  2. PGEN vs BSVN Comparison

PGEN vs BSVN Comparison

Compare PGEN & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • BSVN
  • Stock Information
  • Founded
  • PGEN 1998
  • BSVN 2004
  • Country
  • PGEN United States
  • BSVN United States
  • Employees
  • PGEN N/A
  • BSVN N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • BSVN Major Banks
  • Sector
  • PGEN Health Care
  • BSVN Finance
  • Exchange
  • PGEN Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • PGEN 493.0M
  • BSVN 410.8M
  • IPO Year
  • PGEN N/A
  • BSVN 2018
  • Fundamental
  • Price
  • PGEN $4.14
  • BSVN $49.07
  • Analyst Decision
  • PGEN Buy
  • BSVN Buy
  • Analyst Count
  • PGEN 5
  • BSVN 2
  • Target Price
  • PGEN $7.50
  • BSVN $53.50
  • AVG Volume (30 Days)
  • PGEN 18.8M
  • BSVN 18.3K
  • Earning Date
  • PGEN 08-12-2025
  • BSVN 10-10-2025
  • Dividend Yield
  • PGEN N/A
  • BSVN 1.96%
  • EPS Growth
  • PGEN N/A
  • BSVN 36.51
  • EPS
  • PGEN N/A
  • BSVN 4.65
  • Revenue
  • PGEN $4,340,000.00
  • BSVN $96,069,000.00
  • Revenue This Year
  • PGEN $253.63
  • BSVN N/A
  • Revenue Next Year
  • PGEN $699.64
  • BSVN $4.37
  • P/E Ratio
  • PGEN N/A
  • BSVN $10.53
  • Revenue Growth
  • PGEN N/A
  • BSVN 22.27
  • 52 Week Low
  • PGEN $0.65
  • BSVN $32.49
  • 52 Week High
  • PGEN $5.23
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 64.19
  • BSVN 59.14
  • Support Level
  • PGEN $3.89
  • BSVN $48.33
  • Resistance Level
  • PGEN $5.23
  • BSVN $50.10
  • Average True Range (ATR)
  • PGEN 0.36
  • BSVN 0.97
  • MACD
  • PGEN -0.09
  • BSVN -0.10
  • Stochastic Oscillator
  • PGEN 32.30
  • BSVN 67.14

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: